A Trusted Partner Providing
Reliable Information on Medicines

  • slide
  • slide
  • slide
  • slide
  • Mobile App

    Mobile App


Jun 9, 2014, 5:20 PM
In the last 9 months, over 153,000 unique visitors from 174 countries have accessed the CredibleMeds® website. This represents a 29 increase and 48% of visitors are from outside the U.S.
May 20, 2014, 5:22 PM
Using the list of QT prolonging drugs from the CredibleMeds website and patient information in the electronic health records, the CDSS automatically generated a risk score for QT prolongation and issued alerts to pharmacists (high risk or moderate risk).
Apr 17, 2014, 5:25 PM
Nelfinavir (Viracept®) and Ivabradine (Procoralan®, Coralan®, Corlentor®, Coraxan®, Ivabid®, Bradia®) have been added to the list of medicines with Conditional Risk of Torsades de Pointes (TdP).
Mar 31, 2014, 5:30 PM
Azithromycin has been associated with increased risk of death(1) and since June 2012 has been on the CredibleMeds list of QT-prolonging drugs that have “Known Risk of Torsades de Pointes (TdP).”
Feb 11, 2014, 5:32 PM
Research at AZCERT has documented the greater sensitivity of women to the effects of medicines that have effects on the heart and prolong the QT interval on the ECG, the influence of their menstrual cycle and the corresponding increase in life-threatening arrhythmias and deaths in women.
Jan 13, 2014, 5:34 PM
CredibleMeds® is pleased to announce that My Medicines Forms, our new record-keeping and notification system, is now available.
Aug 21, 2013, 5:37 PM
CredibleMeds'® releases CredibleCDS™ - an open-source drug safety resource for use in clinical decision support systems.
Jun 30, 2013, 5:35 PM
Nature Reviews of Cardiology invited Dr. Raymond L. Woosley to author an article, assessing cardiovascular drug safety for clinical decision-making which appears in Volume 10 of the Cardiology Review.
Mar 22, 2013, 5:39 PM
The Annual Review of Pharmacology and Toxicology invited Dr. Raymond Woosley to author an article on the past, present and future of drug regulation which appears in Volume 53 of the Review.